We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $71.2B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
-3.02%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
AUM
$61.9B
AUM Growth
-$2.65B
Cap. Flow
+$879M
Cap. Flow %
1.42%
Top 10 Hldgs %
36.04%
Holding
975
New
39
Increased
486
Reduced
379
Closed
44

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$130M
2
MSFT icon
Microsoft
MSFT
+$78.5M
3
NVDA icon
NVIDIA
NVDA
+$71M
4
AMZN icon
Amazon
AMZN
+$61.8M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.7M

Sector Composition

Rank Sector Weight
1 Technology 31.22%
2 Healthcare 13.42%
3 Consumer Discretionary 10.95%
4 Communication Services 10.94%
5 Financials 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
326
Biogen
BIIB
$30B
$27.7M 0.04%
151,144
+11,266
+8% +$2.08M
RPRX icon
327
Royalty Pharma
RPRX
$25.9B
$27.5M 0.04%
573,746
-87,670
-13% -$3.84M
KKR icon
328
KKR & Co
KKR
$91.1B
$27.5M 0.04%
297,047
+37,390
+14% +$3.94M
APD icon
329
Air Products & Chemicals
APD
$65.7B
$27.4M 0.04%
94,167
+2,738
+3% +$755K
ACGL icon
330
Arch Capital
ACGL
$34.3B
$27.3M 0.04%
284,873
+7,084
+3% +$678K
D icon
331
Dominion Energy
D
$60.8B
$27.3M 0.04%
442,173
+14,012
+3% +$865K
CBOE icon
332
Cboe Global Markets
CBOE
$32.5B
$27.3M 0.04%
97,127
+622
+0.6% +$173K
MPC icon
333
Marathon Petroleum
MPC
$92.4B
$26.9M 0.04%
110,299
+4,154
+4% +$839K
NAMS icon
334
NewAmsterdam Pharma
NAMS
$3.25B
$26.8M 0.04%
837,005
+107,521
+15% +$3.5M
VIAV icon
335
Viavi Solutions
VIAV
$9.12B
$26.7M 0.04%
802,609
-796,078
-50% -$21M
MTD icon
336
Mettler-Toledo International
MTD
$28.6B
$26.6M 0.04%
21,067
+311
+1% +$420K
FITB
337
Fifth Third Bancorp
FITB
$51.2B
$26.4M 0.04%
567,304
+30,604
+6% +$1.51M
TTWO icon
338
Take-Two Interactive
TTWO
$45.4B
$26.3M 0.04%
132,999
+10,072
+8% +$2.19M
FSLR icon
339
First Solar
FSLR
$22.7B
$26.3M 0.04%
133,096
+1,567
+1% +$347K
OTIS icon
340
Otis Worldwide
OTIS
$27.4B
$26M 0.04%
337,880
+11,482
+4% +$1M
EWTX icon
341
Edgewise Therapeutics
EWTX
$4.13B
$26M 0.04%
826,059
+4,119
+0.5% +$119K
DYN icon
342
Dyne Therapeutics
DYN
$4.7B
$25.9M 0.04%
1,430,384
+322,239
+29% +$5.56M
TDY icon
343
Teledyne Technologies
TDY
$30.4B
$25.8M 0.04%
42,703
+1,638
+4% +$1.02M
CPT icon
344
Camden Property Trust
CPT
$11B
$25.7M 0.04%
263,225
+27,700
+12% +$2.94M
DD icon
345
DuPont de Nemours
DD
$18.5B
$25.7M 0.04%
186,707
+24,501
+15% +$3.38M
WSFS icon
346
WSFS Financial
WSFS
$4.12B
$25.6M 0.04%
391,077
+7,865
+2% +$496K
DOV icon
347
Dover
DOV
$27.6B
$25.5M 0.04%
122,517
+3,779
+3% +$808K
RIVN icon
348
Rivian
RIVN
$22B
$25.5M 0.04%
1,693,854
+44,193
+3% +$706K
APP icon
349
Applovin
APP
$133B
$25.4M 0.04%
63,697
-3,490
-5% -$1.69M
KVUE icon
350
Kenvue
KVUE
$36.9B
$25.3M 0.04%
1,470,240
+66,765
+5% +$1.19M

Similar funds

Aberdeen Group's Q1 2026 Portfolio in Review

As of Q1 2026, Aberdeen Group held 975 positions worth $61.9B, down 4.1% from $64.6B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Aberdeen Group's Q1 2026 filing shows 39 new, 486 increased, 379 reduced and 44 closed positions. Its largest new stake was Veradermics Inc: 1,054,660 shares worth $66.6M. The largest sale was Spotify, an estimated $107M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aberdeen Group's largest Q1 2026 buy was Veradermics Inc: 1,054,660 shares worth $66.6M.
  • Aberdeen Group added most to Apple in Q1 2026, an estimated $130M increase.
  • Aberdeen Group's biggest Q1 2026 reduction was Spotify, cutting an estimated $107M.
  • Aberdeen Group fully exited Vertex in Q1 2026, selling an estimated $24.4M.
  • Aberdeen Group's ten largest holdings make up 36% of its $61.9B portfolio in Q1 2026.
  • Aberdeen Group opened 39 new positions and closed 44 in Q1 2026.
  • Aberdeen Group's portfolio value fell 4.1% quarter-over-quarter to $61.9B.

Based on Aberdeen Group's 13F filing for Q1 2026, filed 29 Apr 2026.